The above studies examined the role of chemerin in NSCLC; however, at present, no studies examine serum or tissue levels of chemerin in patients with small-cell lung cancer, and only a single study examines its role in other forms of lung cancer. This evidence concerns the gene RARRES2 and small cell lung carcinoma.